HYDERABAD, July 05, 2014 :
Pharma major Dr Reddy’s Laboratories has launched Duloxetine delayed release capsules in the US market. The anti-depressant drug is the generic equivalent of Cymbalta.
The brand and generic had a sales of $5 billion in the US in the 12 months ended April 2014, according to a release. The company’s scrip gained 1.93 per cent on the BSE on Friday to close at Rs.2553.15 .
· World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…
Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Winter weather brings a host…
By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…
Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…
Coimbatore, October 30, 2024: Sri Ramakrishna Hospital’s Neurology experts observes “World Stroke Day” on October…